92 related articles for article (PubMed ID: 21157217)
21. Al18F-NOTA-Octreotide PET/CT and 18F-FDG PET/CT for Detecting Cerebellar Hemangioblastoma in a Patient With Von Hippel-Lindau Disease.
Hou G; Cheng X; Chi Y; Wang X; Zheng R
Clin Nucl Med; 2024 Mar; 49(3):289-291. PubMed ID: 38306383
[TBL] [Abstract][Full Text] [Related]
22. Paediatric metastatic ganglioneuroblastoma on 68Ga-DOTA NOC PET-CT.
Usmani S; Al-Mohtab S; Albader FL; Kandari FA
J Pak Med Assoc; 2023 Jan; 73(1):202-203. PubMed ID: 36842043
[TBL] [Abstract][Full Text] [Related]
23. FDG PET/CT detects clinically occult pancreatic cancer in a case of Von Hippel-Lindau syndrome.
Kulkarni M; Purandare N; Zade A; Agrawal A; Shah S; Rangarajan V
Clin Nucl Med; 2013 Jul; 38(7):e302-3. PubMed ID: 23486326
[TBL] [Abstract][Full Text] [Related]
24. 68Ga DOTANOC PET/CT detects medullary thyroid cancer relapse at bone level.
Nicolini S; Ambrosini V; Fantini L; Fanti S
Clin Nucl Med; 2012 Jun; 37(6):591-2. PubMed ID: 22614194
[TBL] [Abstract][Full Text] [Related]
25. The role of 6-[18F]fluorodopamine positron emission tomography in the localization of adrenal pheochromocytoma associated with von Hippel-Lindau syndrome.
Kaji P; Carrasquillo JA; Linehan WM; Chen CC; Eisenhofer G; Pinto PA; Lai EW; Pacak K
Eur J Endocrinol; 2007 Apr; 156(4):483-7. PubMed ID: 17389464
[TBL] [Abstract][Full Text] [Related]
26. 'Reverse discordance' between 68Ga-DOTA-NOC PET/CT and 177Lu-DOTA-TATE posttherapy scan: the plausible explanations and its implications for high-dose therapy with radiolabeled somatostatin receptor analogs.
Basu S; Abhyankar A; Kand P; Kumar R; Asopa R; Rajan MG; Nayak U; Shimpi H; Das T; Venkatesh M; Chakrabarty S; Banerjee S
Nucl Med Commun; 2011 Jul; 32(7):654-8. PubMed ID: 21654355
[TBL] [Abstract][Full Text] [Related]
27. The natural history of renal lesions in von Hippel-Lindau disease: a serial CT study in 28 patients.
Choyke PL; Glenn GM; Walther MM; Zbar B; Weiss GH; Alexander RB; Hayes WS; Long JP; Thakore KN; Linehan WM
AJR Am J Roentgenol; 1992 Dec; 159(6):1229-34. PubMed ID: 1442389
[TBL] [Abstract][Full Text] [Related]
28. Evaluation of unusual neuroendocrine tumours by means of 68Ga-DOTA-NOC PET.
Fanti S; Ambrosini V; Tomassetti P; Castellucci P; Montini G; Allegri V; Grassetto G; Rubello D; Nanni C; Franchi R
Biomed Pharmacother; 2008 Dec; 62(10):667-71. PubMed ID: 18358680
[TBL] [Abstract][Full Text] [Related]
29. Indium-111 pentetreotide uptake within cerebellar hemangioblastoma in von Hippel-lindau syndrome.
Chowdhury FU; Scarsbrook AF
Clin Nucl Med; 2008 Apr; 33(4):294-6. PubMed ID: 18356676
[TBL] [Abstract][Full Text] [Related]
30. [Epidemiology, treatment and follow-up of central nervous system hemangioblastomas in von Hippel-Lindau disease].
Sankaredja J; Brac B; Thines L; Baroncini M; Zairi F; Cardot-Bauters C; Lejeune JP
Rev Neurol (Paris); 2014 Apr; 170(4):288-96. PubMed ID: 24680832
[TBL] [Abstract][Full Text] [Related]
31. In vivo visualization of somatostatin receptor expression with Ga-68-DOTA-TATE PET/CT in advanced metastatic prostate cancer.
Alonso O; Gambini JP; Lago G; Gaudiano J; Quagliata A; Engler H
Clin Nucl Med; 2011 Nov; 36(11):1063-4. PubMed ID: 21975409
[No Abstract] [Full Text] [Related]
32. 68 Ga-DOTANOC PET/CT in 2 Siblings With Von Hippel-Lindau Disease.
G B P; Damle NA; Reddy K R; Tandon N; Naranje P; Kandasamy D; Subudhi K
Clin Nucl Med; 2024 Jun; 49(6):e266-e268. PubMed ID: 38537203
[TBL] [Abstract][Full Text] [Related]
33. Pancreatic lesions in von Hippel-Lindau disease: prevalence, clinical significance, and CT findings.
Hough DM; Stephens DH; Johnson CD; Binkovitz LA
AJR Am J Roentgenol; 1994 May; 162(5):1091-4. PubMed ID: 8165988
[TBL] [Abstract][Full Text] [Related]
34. 68Ga-DOTANOC PET-CT demonstrating in vivo somatostatin receptor expression in idiopathic gynecomastia.
Dhull VS; Sharma P; Singla S; Singhal A; Bal C; Kumar R
Clin Nucl Med; 2013 Aug; 38(8):e324-5. PubMed ID: 23531768
[TBL] [Abstract][Full Text] [Related]
35. The role of 68Ga-DOTATATE PET in patients with neuroendocrine tumors and negative or equivocal findings on 111In-DTPA-octreotide scintigraphy.
Srirajaskanthan R; Kayani I; Quigley AM; Soh J; Caplin ME; Bomanji J
J Nucl Med; 2010 Jun; 51(6):875-82. PubMed ID: 20484441
[TBL] [Abstract][Full Text] [Related]
36. Evaluation of feasibility and image quality of 68Ga-DOTATOC positron emission tomography/magnetic resonance in comparison with positron emission tomography/computed tomography in patients with neuroendocrine tumors.
Gaertner FC; Beer AJ; Souvatzoglou M; Eiber M; Fürst S; Ziegler SI; Brohl F; Schwaiger M; Scheidhauer K
Invest Radiol; 2013 May; 48(5):263-72. PubMed ID: 23385399
[TBL] [Abstract][Full Text] [Related]
37. CT screening of the abdomen in von Hippel-Lindau disease.
Levine E; Collins DL; Horton WA; Schimke RN
AJR Am J Roentgenol; 1982 Sep; 139(3):505-10. PubMed ID: 6981314
[TBL] [Abstract][Full Text] [Related]
38. Hemangioblastomas of the central nervous system. A 10-year study with special reference to von Hippel-Lindau syndrome.
Neumann HP; Eggert HR; Weigel K; Friedburg H; Wiestler OD; Schollmeyer P
J Neurosurg; 1989 Jan; 70(1):24-30. PubMed ID: 2909683
[TBL] [Abstract][Full Text] [Related]
39. The natural history of renal lesions in von Hippel-Lindau disease: a serial CT study in 28 patients.
Goldman SM
J Urol; 1993 Apr; 149(4):940-1. PubMed ID: 8455278
[No Abstract] [Full Text] [Related]
40. 68Ga-DOTANOC PET/CT in Adrenal Schwannoma.
Aggarwal P; Singh H; Kumar R; Nada R; Bora GS; Walia R
Clin Nucl Med; 2023 Jan; 48(1):e22-e23. PubMed ID: 36469076
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
